Purchase Order 15B50525P00000024

Award Date 11/1/24
Potential Completion Date 11/30/24
Potential Value $22K
Ultimate Awardee
Mckesson Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cary, NC 27513, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $22,061.05 firm fixed-price purchase order awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation, for the supply of cancer drugs and biologics in fiscal year 2025. The contract has no set-aside designation, indicating open competition. Biologics, Inc. is a pharmaceutical company focused on delivering critical medical treatments, particularly cancer medications, to various federal healthcare and correctional...
This is a firm fixed-price purchase order contract awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation. The $22,061.05 contract is for the delivery of cancer drugs and biologics to the agency in July 2025. The contract has no set-aside designation, indicating open competition. As a specialized pharmaceutical provider, Biologics, Inc. has a history of delivering critical medical treatments, particularly cancer medications, to...
This is a $20,432.27 firm fixed-price purchase order awarded by the Veterans Integrated Service Network 19 (VISN 19), a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation, for the emergency procurement of the cancer medication Lenalidomide. The contract has an ultimate completion date of September 30, 2025 and was awarded on August 21, 2025. Biologics, Inc. is a for-profit pharmaceutical company that specializes in delivering critical medical treatments, particularly...
This is a firm fixed-price purchase order for $91,279.43 awarded by the Veterans Integrated Service Network 22, a component of the Department of Veterans Affairs (VA), to Biologics, Inc. to provide the cancer medication Lynparza on an emergency basis. The contract period was from November 6, 2015 to September 30, 2016. This contract was not set aside for any specific business category. Biologics, Inc. is a for-profit pharmaceutical company that has provided specialty medications to various...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 21 (VISN 21), a civilian agency within the Department of Veterans Affairs, to Biologics, Inc., a for-profit pharmaceutical company and subsidiary of McKesson Corporation. The contract is for the supply of LENALIDOMIDE 5MG NDC: 76282-0697-48, a cancer medication, with a ceiling value of $18,697.14 and a completion date of November 23, 2025. The contract was competitively awarded and does not have...
This is a $109,871.18 firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Mckesson Corporation, doing business as Mckesson Drug Company, a for-profit healthcare services and IT company. The award is not associated with any set-aside program. Mckesson has a history of providing pharmaceutical products such as penicillin injections and alvimopan capsules to the Department of Veterans Affairs' Veterans Health Administration and the Indian Health...
This is a $314,325.48 firm fixed price delivery order contract awarded by the Department of Defense's Medical Supply Chain organization to Mckesson Corporation, doing business as Mckesson Drug Company. The contract was not set aside for any special program. The contract provides for the delivery of unspecified pharmaceutical products to support military treatment facilities. Mckesson has previously provided items such as penicillin injections and alvimopan capsules to the Department of...
This is a firm fixed price delivery order for $24,671,061.83 awarded to McKesson Corporation, a healthcare services and information technology company, by the Veterans Integrated Service Network 20 of the Department of Veterans Affairs. The delivery order is for the provision of pharmaceutical products and services, including HIV medications, specialty pharmaceuticals, medication-assisted treatment drugs, COVID-19 vaccines, and clinical pharmacy supplies, to various federal agencies such as...
This is a $205,521.48 firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical branch to Mckesson Corporation, doing business as Mckesson Drug Company. The delivery order is for the provision of unspecified pharmaceutical items to military treatment facilities. No set-aside designation was used. Mckesson is a healthcare services and information technology company that provides pharmaceuticals, medical supplies, and related distribution services to federal...
This is a $957,755.21 firm fixed-price delivery order awarded by the Medical Supply Chain branch of the Department of Defense's Defense Logistics Agency to Mckesson Corporation, a healthcare services and IT company, for the provision of pharmaceutical products. The award is not associated with a set-aside designation. Based on the contract details, Mckesson has provided over $5.8 million in pharmaceutical items such as penicillin injections and alvimopan capsules to the Department of Health...

This is a $21,535.58 firm fixed-price purchase order awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a for-profit pharmaceutical provider. The order is for cancer drug biologics to be delivered by November 30, 2024. Biologics, Inc. is a subsidiary of the larger McKesson Corporation, which is a major healthcare services and IT company that has provided over $5.8 million in pharmaceutical products to the Department of Veterans Affairs and Indian Health Service under various contract vehicles. This order does not have a set-aside designation.

Generated 11/22/24, 9:11 AM